Excella Life Sciences Private Limited, a active private limited company, was established on 21 April 2005 in New Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24333DL2005PTC135229. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹3.00 M and a paid-up capital of ₹3.00 M.
It upholds a active non-compliant status. Employing 6 professional, Its leadership includes Vidya Bharti Koul (Director), Rakesh Koul (Director). Past directors included Sanjeev Kansal, Kusam Devi. It holds ₹10.35 Cr open charges and ₹9.97 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 101, Progressive House, First Floor, Rohit Kunj Market, Pitam Pura, New Delhi, Delhi, 110034.
U24333DL2005PTC135229
135229
21 April 2005
₹3.00 M
₹3.00 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Excella Life Sciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vidya Bharti Koul | Director | 21 Apr 2005 | Current |
| Rakesh Koul | Director | 15 Apr 2010 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Feb 2009 | Past |
| Pramod Abcsdd | Director | 24 Dec 2010 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Excella Life Sciences Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 2.75% decrease. The company also saw a slight improvement in profitability, with a 2.17% increase in profit. The company's net worth observed a substantial decline by a decrease of 119.85%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Excella Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹103,461,000.00
₹99,745,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Mar 2017 | Hdfc Bank Limited | ₹7.17 Cr | Open |
| 10 Aug 2016 | Others | ₹1.50 M | Open |
| 27 Feb 2013 | Punjab National Bank | ₹0.95 M | Open |
| 03 May 2010 | Punjab National Bank | ₹1.32 Cr | Open |
| 31 Aug 2009 | Indiabulls Financial Services Limited | ₹1.01 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Excella Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Excella Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Excella Life Sciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Excella Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
Progress on Excella Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was documented.
A charge with Hdfc Bank Limited of Rs. 71.70 M registered on 10 Mar 2017 with Charge ID 100091771 was modified on 19 Jun 2020. was recorded as a recent event.
Progress on A charge registered on 21 May 2010 via Charge ID 10220670 with S. E. Investments Limited was fully satisfied on 18 May 2017. was documented.
The activity A charge registered on 20 Jan 2017 via Charge ID 100076762 with Others was fully satisfied on 08 May 2017. was completed.
Progress on A charge registered on 08 Sep 2014 via Charge ID 10543903 with Punjab National Bank was fully satisfied on 08 May 2017. was documented.
The CIN of Excella Life Sciences Private Limited is U24333DL2005PTC135229.
Excella Life Sciences Private Limited is headquartered at 101, Progressive House, First Floor, Rohit Kunj Market, Pitam Pura, New Delhi, Delhi, 110034.
Excella Life Sciences Private Limited was incorporated on 21 April 2005.
The current directors of Excella Life Sciences Private Limited are
The primary industry of Excella Life Sciences Private Limited is Trade.
Excella Life Sciences Private Limited is unlisted.
The authorized capital of Excella Life Sciences Private Limited is ₹3.00 M, and the paid-up capital is ₹3.00 M.
The compliance status of Excella Life Sciences Private Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX